Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Jul 05, 2019 1:59pm

88 Views

Post# 29890307

RE:RE:RE:RE:RE:RE:RE:Incentives to have a 1st cohort (UHN) 3-month data publish

Skys1 ... Why don't you raise your issues to TLT management, have a chat with them. Maybe they will tell you a reality you and Pee-Wee Yajne haven't understand so far, despite your 54 years of investment. For the rest, it's your money. So your investment decision. You can do whatever you think is best for you. But as far as I'm concerned, it's pretty strange to read what you posted, knowing how close we are to interim Ph. 2b data and knowing that this Ph. 2b is clearly on track. Reading this board, some thought patient enrollment would happen in a blink of an eye. That's their problem.

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle